ArticleClinical pharmacology and therapeutics2017
Corrigendum: The effect of an abuse-deterrent opioid formulation (OxyContin) on opioid abuse-related outcomes in the postmarketing setting.
PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.